On July 7, PeopleBio filed a correction to its previous proxy solicitation document, appointing SCV Partners as the proxy solicitor.
The amendment changes the status of proxy solicitation from not entrusted to entrusted, without affecting the existing shareholder meeting agenda.
The agenda items remain the same: a 2-to-1 stock merge, a name change to TimeX AI, and a capital reduction of 79.2 billion won from share premium to cover accumulated deficits.
[AI Summary]This correction is purely administrative and does not change the financial impact or shareholder value from the originally proposed agenda. While the stock merge reduces outstanding shares and the name change signals strategic shift, no concrete business plans or earnings improvements are provided, making the near-term stock price outlook neutral.
KOSDAQ Filing Information
[Correction of Description] Proxy Solicitation Reference Documents